The disruption has affected access to key operating systems and business applications, including the company's ability to manufacture products and process and ship customer orders. Boston Scientific said it is working to restore affected systems, but a timeline for full recovery has not yet been announced.
The company said its investigation remains ongoing and that the full scope and potential operational or financial impact of the incident are still being assessed. Boston Scientific has also stated that it is prioritizing continuity of supply and patient-related systems during its recovery efforts.



